| Financial Year |
March 31 2023 |
| Monetary Funds |
1,262,774,151.32 |
| Held-for-trading Financial Assets |
1,493,569,729.08 |
| Notes Receivable |
-- |
| Accounts Receivable |
49,012,207.24 |
| Advances to Suppliers |
186,204,823.94 |
| Other Receivables |
7,062,747.10 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
716,846,854.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,364,223.74 |
| Total Current Assets |
3,738,834,737.41 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
8,872,946.45 |
| Fixed Assetes |
578,339,014.38 |
| Under-construction Projects |
5,239,341.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,111,878.06 |
| R&D expenses |
2,772,347.14 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
326,613.30 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
53,968,756.26 |
| Sub-Total of Non-Current Assets |
746,892,750.55 |
| Total Assets |
4,485,727,487.96 |
| Short-Term Loans |
9,550,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
41,562,368.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,546,611.84 |
| Taxes Payable |
2,439,259.27 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
251,725,070.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
103,640,923.99 |
| Sub-Total of Current Liabilities |
762,153,066.11 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
86,348,860.76 |
| Total Liabilities |
848,501,926.87 |
| Paid-In Capital(Or Share Stock) |
880,000,000.00 |
| Capital Surplus |
29,316,990.04 |
| Surplus Reserve |
357,686,681.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,094,506,391.59 |
| Minority Stockholder's Interest |
278,736,484.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,358,489,076.53 |
| Owner's Equity（Stockholder's Equity） |
3,637,225,561.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,485,727,487.96 |
